Nasty US measles outbreak helps boost Merck’s vaccine sales in second quarter

By

Nasty US measles outbreak helps boost Merck's vaccine sales in second quarter

Sales of children vaccines, which includes the New Jersey-based company’s MMR vaccine for measles, jumped 58% year-over-year to $675 million, Merck announced in its second-quarter earnings report.

Source: Business News –

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.